Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Poonglim Pharmatech Inc. currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This activity is concentrated under 1 distinct examiner and 1 distinct art unit. The distribution of 1 distinct examiner and 1 distinct art unit suggests a focused technological scope for the company's current patent filings.
The busiest examiner for this portfolio is RITCHIE, HADEN MATTHEW, who is responsible for 1 busiest examiner pending office action. This examiner handles all of the company's pending workload. Practitioners can expect a consistent examination experience because all current matters are localized under 1 distinct examiner.
The presence of 1 distinct art unit reinforces the specialized nature of the pending work. The 1 pending office action represents the total current administrative burden for the company in this sector. This alignment of 1 pending office action and 1 distinct examiner confirms a lack of examiner diversity in the current docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RITCHIE, HADEN MATTHEW | 1 | 73.4% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17795656 | DRUG INJECTION CONTROL DEVICE FOR PROVIDING IMMEDIATE FEEDBACK DURING THE USE OF DOSE DIAL | RITCHIE, HADEN MATTHEW | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17795656 | DRUG INJECTION CONTROL DEVICE FOR PROVIDING IMMEDIATE FEEDBACK DURING THE USE OF DOSE DIAL | RITCHIE, HADEN MATTHEW | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17795656 | DRUG INJECTION CONTROL DEVICE FOR PROVIDING IMMEDIATE FEEDBACK DURING THE USE OF DOSE DIAL | RITCHIE, HADEN MATTHEW | 3783 | §102§103 | Final Rejection | — | Pending | Jul 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial